Pfizer shares fell after disappointing company profit expectations

Pfizer Pharmaceuticals' share declined on Wall Street yesterday; After a statement by the CEO of the company that the earnings per share for the current year will be less than analysts' expectations.

According to Arabianet, Albert Burla stated that the company's share profit will range between $ 3 and $ 3.10 for the current year, while analysts' expectations indicated a profit of 3 $ 18 a share.

and Burla confirmed that the expected profits include the contribution of the Corona vaccine, which the company launched as it was the first vaccines that were approved in emergency situations in the United States.

The World Health Organization has granted emergency approval for the Pfizer-Biontech vaccine, paving the way for countries around the world to quickly approve its import and distribution.

The organization said in a previous statement that the decision makes the Pfizer - Biontech vaccine the first vaccine to receive emergency approval from the World Health Organization, since the outbreak of the Coronavirus began more than General

"This is a very positive step to ensure that everyone in the world has access to vaccines against the Covid-19 virus," said Mariangela Simao, in charge of obtaining medicines at the World Health Organization in a statement. .

This mechanism, which the organization can resort to in health emergencies, allows countries that do not necessarily have self-sufficient means that allow them to quickly determine the effectiveness of any drug, to obtain Means treat more quickly.

On Thursday, the World Health Organization granted emergency certification of the Pfizer-Biontech vaccine, paving the way for countries around the world to quickly approve its import and distribution.

The organization said in a statement, that the decision makes the Pfizer - Biontech vaccine the first vaccine to receive emergency approval from the World Health Organization, since the outbreak of the Coronavirus began more than General

"This is a very positive step to ensure that everyone in the world has access to vaccines against the Covid-19 virus," said Mariangela Simao, in charge of obtaining medicines at the World Health Organization in a statement .

This mechanism that WHO can resort to in health emergencies enables countries that do not necessarily have self-sufficient means that allow them to quickly determine the effectiveness of any drug, to obtain Means treat more quickly.